21 results found
The Sino-Russian biotechnology collaboration, augmented by its strategic focus on pharmaceuticals and economic growth, has called for a global concern
This brief analyses the regulatory, security and ethical challenges facing states and the international community regarding emerging technologies in biotechnology, focusing on the CRISPR/Cas9 gene editing system and artificial gene synthesis. It highlights the inadequacy of current mechanisms such as export control regimes to regulate these emerging technologies because of a fundamental shift in the nature of challenges posed and an altered globa
As the biotechnology industry evolves, integrating synthetic data and model-based reasoning will remain crucial for addressing complex biological chal
As genetic engineering continues to grow and find more avenues of impact, the need to optimise and regulate this technology will also heighten
While addressing aspects of the synergy between Artificial Intelligence (AI) and biotechnology, the existing regulatory landscape will need more expli
In the biomedical field, laboratories must ensure biosafety while managing pathogens and microorganisms in order to protect personnel and the broader community against potential leaks and lab-acquired infections. Global standards provide a roadmap for the biosafety of laboratories, underscoring the importance of their design and equipment, personnel training, waste management, and communication in preventing potential biohazards from breaching co
Biological weapons can come from naturally occurring microbes and viruses; but innovations in genomic editing are opening up new, potentially more threatening avenues for their development. These innovations can cause or spread disease or resist known therapeutic approaches. Addressing such threats of biowarfare requires obtaining reliable and informative taxonomies for the pathogens and timely and effective responses. This, in turn, calls for co
As the ecosystem evolves and companies mature, there are dire requirements for the next phase of innovation driven growth.
Biotechnology emerging as a major element in global power equations
Since its inception, DBT has been committed to delivering solutions for societal challenges with a focus on Make in India.
चीनी-रशियन बायोटेक्नॉलॉजीच्या सहकार्यामुळे फार्मास्य�
अपनी स्थापना के साथ ही जैव प्रौद्योगिकी विभाग ने खुद को स�
जैवबँक हा जैवभांडाराचा एक प्रकार आहे, ज्यात जीवशास्त्रीय संशोधनात वापरण्यासाठीचे जैविक नमुने (सामान्यतः मानवी) संग्रहित केले जातात आणि त्याचे परिणाम विविध देशांतील लो�
फार्मास्यूटिकल्स और आर्थिक वृद्धि पर रणनीतिक ज़ोर के बू�
চিন–রাশিয়া জৈবপ্রযুক্তি সহযোগিতা, যা ফার্মাসিউটিক্যা�
मानवाच्या अनेक गुंतागुंतीच्या आणि जटिल अशा अडचणी सोडविण्यासाठी जीवशास्त्र हे हुकुमाचे अस्त्र आहे. त्यामुळे पर्यावरणाचा समतोल साधता येतो.
